Log in to save to my catalogue

Injectable amnion hydrogel-mediated delivery of adipose-derived stem cells for osteoarthritis treatm...

Injectable amnion hydrogel-mediated delivery of adipose-derived stem cells for osteoarthritis treatm...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8794776

Injectable amnion hydrogel-mediated delivery of adipose-derived stem cells for osteoarthritis treatment

About this item

Full title

Injectable amnion hydrogel-mediated delivery of adipose-derived stem cells for osteoarthritis treatment

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2022-01, Vol.119 (4), p.1-10

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

Current treatment strategies for osteoarthritis (OA) predominantly address symptoms with limited disease-modifying potential. There is a growing interest in the use of adipose-derived stem cells (ADSCs) for OA treatment and developing biomimetic injectable hydrogels as cell delivery systems. Biomimetic injectable hydrogels can simulate the native t...

Alternative Titles

Full title

Injectable amnion hydrogel-mediated delivery of adipose-derived stem cells for osteoarthritis treatment

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8794776

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8794776

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.2120968119

How to access this item